The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival

Tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and monocyte chemoattractant protein-1 (MCP-1) are early phase cytokines often encountered when the body is exposed to severe acute respiratory syndrome-associated-coronavirus-2. TNF-α, IL-1β, and MCP-1 are pro-inflammatory cytokines critical...

Full description

Saved in:
Bibliographic Details
Published in:Infection and drug resistance 2022-01, Vol.15, p.821-829
Main Authors: Kumboyono, Kumboyono, Chomsy, Indah Nur, Iskandar, Agustin, Aryati, Aryati, Parwati, Ida, Wihastuti, Titin Andri
Format: Article
Language:English
Subjects:
Coronaviruses
COVID-19
cytokine
Disseminated infection
Enzyme-linked immunosorbent assay
IL-1β
Inflammation
Monocyte chemoattractant protein
Monocyte chemoattractant protein 1
Monocytes
Mortality
Original Research
Patients
Polymerase chain reaction
sars cov-2
Severe acute respiratory syndrome
Survival
survival predictors
Tumor necrosis factor-TNF
Tumor necrosis factor-α
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c475t-71176325ddfff0fe82fce58ea4f13481097b8211a5a5fc0b67e9dc47f53791e63
cites cdi_FETCH-LOGICAL-c475t-71176325ddfff0fe82fce58ea4f13481097b8211a5a5fc0b67e9dc47f53791e63
container_end_page 829
container_issue
container_start_page 821
container_title Infection and drug resistance
container_volume 15
creator Kumboyono, Kumboyono
Chomsy, Indah Nur
Iskandar, Agustin
Aryati, Aryati
Parwati, Ida
Wihastuti, Titin Andri
description Tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and monocyte chemoattractant protein-1 (MCP-1) are early phase cytokines often encountered when the body is exposed to severe acute respiratory syndrome-associated-coronavirus-2. TNF-α, IL-1β, and MCP-1 are pro-inflammatory cytokines critical in the defence response against systemic infection and injury. Therefore, TNF-α, IL-1β, and MCP-1 are the most aggressive responses to viral infections in the acute phase, so they can be used to determine the survival of coronavirus disease 2019 (COVID-19) patients. The study aimed to determine the levels of TNF-α, IL-1β, and MCP-1 as predictors of survival for COVID-19 patients. A prospective cohort study was conducted on confirmed COVID-19 by a reverse-transcriptase-polymerase-chain-reaction (RT-PCR) in 84 adults admitted to the hospital in Indonesia. TNF-α, IL-1β, and MCP-1 level were measured from serum subjects using the enzyme-linked immunosorbent assay. The results from logistic regression modelling of the survival status of COVID-19 patients based on TNF-α, IL-1β, and MCP-1 levels were significant (p-value=0.024). The predictors of all cytokines had P Wald
doi_str_mv 10.2147/IDR.S348392
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_525f6e857cfd469d8ccf176d78601634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_525f6e857cfd469d8ccf176d78601634</doaj_id><sourcerecordid>2638945149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-71176325ddfff0fe82fce58ea4f13481097b8211a5a5fc0b67e9dc47f53791e63</originalsourceid><addsrcrecordid>eNpdks9uEzEQxlcIRKvSE3dkiQsS3bJe_78gVSmFlQqN2sDVcrzjxmGzLl5vpL4GbwIP0mfCIaFq8cWW_ZtvZjxfUbzE1XGNqXjXnF4eXxEqiaqfFPsYC1lyJcjTB-e94nAYllVeRHEq6ufFHmG1xEzg_eLnbAFoGhL0yZsOTSO03ia_BnQZOkDBodm4CmNEX8DGMPgBnRmbQizvfh2hpk8QOxi_-77Ed7-PkOlb9Dn0wd4mQJMFrIJJKeYA06esndNsSORCRJOLb81piRWamuRz9gFdjXHt16Z7UTxzphvgcLcfFF_PPswmn8rzi4_N5OS8tFSwVIrcICc1a1vnXOVA1s4Ck2Cow_lDcKXEXNYYG2aYs9WcC1BtDnWMCIWBk4Oi2eq2wSz1TfQrE291MF7_vQjxWpuYvO1As5o5DpIJ61rKVSutdTl7KySvMCc0a73fat2M8xW0NjcUTfdI9PFL7xf6Oqy1VBWlZFPMm51ADD9GGJJe-cFC15kewjjomhOpKMNUZfT1f-gyD6jPX5UpypTkRLFMvd1Sm7ENEdx9MbjSG-vobB29s06mXz2s_579ZxTyBx0CwD0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2645986395</pqid></control><display><type>article</type><title>The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Taylor &amp; Francis Open Access</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Kumboyono, Kumboyono ; Chomsy, Indah Nur ; Iskandar, Agustin ; Aryati, Aryati ; Parwati, Ida ; Wihastuti, Titin Andri</creator><creatorcontrib>Kumboyono, Kumboyono ; Chomsy, Indah Nur ; Iskandar, Agustin ; Aryati, Aryati ; Parwati, Ida ; Wihastuti, Titin Andri</creatorcontrib><description>Tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and monocyte chemoattractant protein-1 (MCP-1) are early phase cytokines often encountered when the body is exposed to severe acute respiratory syndrome-associated-coronavirus-2. TNF-α, IL-1β, and MCP-1 are pro-inflammatory cytokines critical in the defence response against systemic infection and injury. Therefore, TNF-α, IL-1β, and MCP-1 are the most aggressive responses to viral infections in the acute phase, so they can be used to determine the survival of coronavirus disease 2019 (COVID-19) patients. The study aimed to determine the levels of TNF-α, IL-1β, and MCP-1 as predictors of survival for COVID-19 patients. A prospective cohort study was conducted on confirmed COVID-19 by a reverse-transcriptase-polymerase-chain-reaction (RT-PCR) in 84 adults admitted to the hospital in Indonesia. TNF-α, IL-1β, and MCP-1 level were measured from serum subjects using the enzyme-linked immunosorbent assay. The results from logistic regression modelling of the survival status of COVID-19 patients based on TNF-α, IL-1β, and MCP-1 levels were significant (p-value=0.024). The predictors of all cytokines had P Wald &lt;0.05, so the three cytokines could be used simultaneously to predict the survival status of COVID-19 patients. MCP-1 has the most dominant risk relative value (2.76; 95% CI; 2.53-4.68) compared to TNF-α and IL-1β in predicting patient survival. TNF-α, IL-1β, and MCP-1 as markers of acute systemic inflammatory cytokines can be measured at the beginning of hospitalisation of COVID-19 patients for early diagnosis of disease severity so that healthcare professionals can determine clinical guidance needs for therapeutic programs.</description><identifier>ISSN: 1178-6973</identifier><identifier>EISSN: 1178-6973</identifier><identifier>DOI: 10.2147/IDR.S348392</identifier><identifier>PMID: 35281571</identifier><language>eng</language><publisher>New Zealand: Taylor &amp; Francis Ltd</publisher><subject>Coronaviruses ; COVID-19 ; cytokine ; Disseminated infection ; Enzyme-linked immunosorbent assay ; IL-1β ; Inflammation ; Monocyte chemoattractant protein ; Monocyte chemoattractant protein 1 ; Monocytes ; Mortality ; Original Research ; Patients ; Polymerase chain reaction ; sars cov-2 ; Severe acute respiratory syndrome ; Survival ; survival predictors ; Tumor necrosis factor-TNF ; Tumor necrosis factor-α ; Tumors</subject><ispartof>Infection and drug resistance, 2022-01, Vol.15, p.821-829</ispartof><rights>2022 Kumboyono et al.</rights><rights>2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Kumboyono et al. 2022 Kumboyono et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-71176325ddfff0fe82fce58ea4f13481097b8211a5a5fc0b67e9dc47f53791e63</citedby><cites>FETCH-LOGICAL-c475t-71176325ddfff0fe82fce58ea4f13481097b8211a5a5fc0b67e9dc47f53791e63</cites><orcidid>0000-0001-6476-0541 ; 0000-0002-1050-3571 ; 0000-0003-2124-8673</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2645986395/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2645986395?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35281571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumboyono, Kumboyono</creatorcontrib><creatorcontrib>Chomsy, Indah Nur</creatorcontrib><creatorcontrib>Iskandar, Agustin</creatorcontrib><creatorcontrib>Aryati, Aryati</creatorcontrib><creatorcontrib>Parwati, Ida</creatorcontrib><creatorcontrib>Wihastuti, Titin Andri</creatorcontrib><title>The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival</title><title>Infection and drug resistance</title><addtitle>Infect Drug Resist</addtitle><description>Tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and monocyte chemoattractant protein-1 (MCP-1) are early phase cytokines often encountered when the body is exposed to severe acute respiratory syndrome-associated-coronavirus-2. TNF-α, IL-1β, and MCP-1 are pro-inflammatory cytokines critical in the defence response against systemic infection and injury. Therefore, TNF-α, IL-1β, and MCP-1 are the most aggressive responses to viral infections in the acute phase, so they can be used to determine the survival of coronavirus disease 2019 (COVID-19) patients. The study aimed to determine the levels of TNF-α, IL-1β, and MCP-1 as predictors of survival for COVID-19 patients. A prospective cohort study was conducted on confirmed COVID-19 by a reverse-transcriptase-polymerase-chain-reaction (RT-PCR) in 84 adults admitted to the hospital in Indonesia. TNF-α, IL-1β, and MCP-1 level were measured from serum subjects using the enzyme-linked immunosorbent assay. The results from logistic regression modelling of the survival status of COVID-19 patients based on TNF-α, IL-1β, and MCP-1 levels were significant (p-value=0.024). The predictors of all cytokines had P Wald &lt;0.05, so the three cytokines could be used simultaneously to predict the survival status of COVID-19 patients. MCP-1 has the most dominant risk relative value (2.76; 95% CI; 2.53-4.68) compared to TNF-α and IL-1β in predicting patient survival. TNF-α, IL-1β, and MCP-1 as markers of acute systemic inflammatory cytokines can be measured at the beginning of hospitalisation of COVID-19 patients for early diagnosis of disease severity so that healthcare professionals can determine clinical guidance needs for therapeutic programs.</description><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>cytokine</subject><subject>Disseminated infection</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>IL-1β</subject><subject>Inflammation</subject><subject>Monocyte chemoattractant protein</subject><subject>Monocyte chemoattractant protein 1</subject><subject>Monocytes</subject><subject>Mortality</subject><subject>Original Research</subject><subject>Patients</subject><subject>Polymerase chain reaction</subject><subject>sars cov-2</subject><subject>Severe acute respiratory syndrome</subject><subject>Survival</subject><subject>survival predictors</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumor necrosis factor-α</subject><subject>Tumors</subject><issn>1178-6973</issn><issn>1178-6973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks9uEzEQxlcIRKvSE3dkiQsS3bJe_78gVSmFlQqN2sDVcrzjxmGzLl5vpL4GbwIP0mfCIaFq8cWW_ZtvZjxfUbzE1XGNqXjXnF4eXxEqiaqfFPsYC1lyJcjTB-e94nAYllVeRHEq6ufFHmG1xEzg_eLnbAFoGhL0yZsOTSO03ia_BnQZOkDBodm4CmNEX8DGMPgBnRmbQizvfh2hpk8QOxi_-77Ed7-PkOlb9Dn0wd4mQJMFrIJJKeYA06esndNsSORCRJOLb81piRWamuRz9gFdjXHt16Z7UTxzphvgcLcfFF_PPswmn8rzi4_N5OS8tFSwVIrcICc1a1vnXOVA1s4Ck2Cow_lDcKXEXNYYG2aYs9WcC1BtDnWMCIWBk4Oi2eq2wSz1TfQrE291MF7_vQjxWpuYvO1As5o5DpIJ61rKVSutdTl7KySvMCc0a73fat2M8xW0NjcUTfdI9PFL7xf6Oqy1VBWlZFPMm51ADD9GGJJe-cFC15kewjjomhOpKMNUZfT1f-gyD6jPX5UpypTkRLFMvd1Sm7ENEdx9MbjSG-vobB29s06mXz2s_579ZxTyBx0CwD0</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Kumboyono, Kumboyono</creator><creator>Chomsy, Indah Nur</creator><creator>Iskandar, Agustin</creator><creator>Aryati, Aryati</creator><creator>Parwati, Ida</creator><creator>Wihastuti, Titin Andri</creator><general>Taylor &amp; Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6476-0541</orcidid><orcidid>https://orcid.org/0000-0002-1050-3571</orcidid><orcidid>https://orcid.org/0000-0003-2124-8673</orcidid></search><sort><creationdate>20220101</creationdate><title>The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival</title><author>Kumboyono, Kumboyono ; Chomsy, Indah Nur ; Iskandar, Agustin ; Aryati, Aryati ; Parwati, Ida ; Wihastuti, Titin Andri</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-71176325ddfff0fe82fce58ea4f13481097b8211a5a5fc0b67e9dc47f53791e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>cytokine</topic><topic>Disseminated infection</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>IL-1β</topic><topic>Inflammation</topic><topic>Monocyte chemoattractant protein</topic><topic>Monocyte chemoattractant protein 1</topic><topic>Monocytes</topic><topic>Mortality</topic><topic>Original Research</topic><topic>Patients</topic><topic>Polymerase chain reaction</topic><topic>sars cov-2</topic><topic>Severe acute respiratory syndrome</topic><topic>Survival</topic><topic>survival predictors</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumor necrosis factor-α</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumboyono, Kumboyono</creatorcontrib><creatorcontrib>Chomsy, Indah Nur</creatorcontrib><creatorcontrib>Iskandar, Agustin</creatorcontrib><creatorcontrib>Aryati, Aryati</creatorcontrib><creatorcontrib>Parwati, Ida</creatorcontrib><creatorcontrib>Wihastuti, Titin Andri</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest research library</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Infection and drug resistance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumboyono, Kumboyono</au><au>Chomsy, Indah Nur</au><au>Iskandar, Agustin</au><au>Aryati, Aryati</au><au>Parwati, Ida</au><au>Wihastuti, Titin Andri</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival</atitle><jtitle>Infection and drug resistance</jtitle><addtitle>Infect Drug Resist</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>15</volume><spage>821</spage><epage>829</epage><pages>821-829</pages><issn>1178-6973</issn><eissn>1178-6973</eissn><abstract>Tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and monocyte chemoattractant protein-1 (MCP-1) are early phase cytokines often encountered when the body is exposed to severe acute respiratory syndrome-associated-coronavirus-2. TNF-α, IL-1β, and MCP-1 are pro-inflammatory cytokines critical in the defence response against systemic infection and injury. Therefore, TNF-α, IL-1β, and MCP-1 are the most aggressive responses to viral infections in the acute phase, so they can be used to determine the survival of coronavirus disease 2019 (COVID-19) patients. The study aimed to determine the levels of TNF-α, IL-1β, and MCP-1 as predictors of survival for COVID-19 patients. A prospective cohort study was conducted on confirmed COVID-19 by a reverse-transcriptase-polymerase-chain-reaction (RT-PCR) in 84 adults admitted to the hospital in Indonesia. TNF-α, IL-1β, and MCP-1 level were measured from serum subjects using the enzyme-linked immunosorbent assay. The results from logistic regression modelling of the survival status of COVID-19 patients based on TNF-α, IL-1β, and MCP-1 levels were significant (p-value=0.024). The predictors of all cytokines had P Wald &lt;0.05, so the three cytokines could be used simultaneously to predict the survival status of COVID-19 patients. MCP-1 has the most dominant risk relative value (2.76; 95% CI; 2.53-4.68) compared to TNF-α and IL-1β in predicting patient survival. TNF-α, IL-1β, and MCP-1 as markers of acute systemic inflammatory cytokines can be measured at the beginning of hospitalisation of COVID-19 patients for early diagnosis of disease severity so that healthcare professionals can determine clinical guidance needs for therapeutic programs.</abstract><cop>New Zealand</cop><pub>Taylor &amp; Francis Ltd</pub><pmid>35281571</pmid><doi>10.2147/IDR.S348392</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6476-0541</orcidid><orcidid>https://orcid.org/0000-0002-1050-3571</orcidid><orcidid>https://orcid.org/0000-0003-2124-8673</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-6973
ispartof Infection and drug resistance, 2022-01, Vol.15, p.821-829
issn 1178-6973
1178-6973
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_525f6e857cfd469d8ccf176d78601634
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Taylor & Francis Open Access; PubMed Central; Coronavirus Research Database
subjects Coronaviruses
COVID-19
cytokine
Disseminated infection
Enzyme-linked immunosorbent assay
IL-1β
Inflammation
Monocyte chemoattractant protein
Monocyte chemoattractant protein 1
Monocytes
Mortality
Original Research
Patients
Polymerase chain reaction
sars cov-2
Severe acute respiratory syndrome
Survival
survival predictors
Tumor necrosis factor-TNF
Tumor necrosis factor-α
Tumors
title The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T15%3A26%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Potential%20Predictive%20Role%20of%20Tumour%20Necrosis%20Factor-%CE%B1,%20Interleukin-1%CE%B2,%20and%20Monocyte%20Chemoattractant%20Protein-1%20for%20COVID-19%20Patients%20Survival&rft.jtitle=Infection%20and%20drug%20resistance&rft.au=Kumboyono,%20Kumboyono&rft.date=2022-01-01&rft.volume=15&rft.spage=821&rft.epage=829&rft.pages=821-829&rft.issn=1178-6973&rft.eissn=1178-6973&rft_id=info:doi/10.2147/IDR.S348392&rft_dat=%3Cproquest_doaj_%3E2638945149%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-71176325ddfff0fe82fce58ea4f13481097b8211a5a5fc0b67e9dc47f53791e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2645986395&rft_id=info:pmid/35281571&rfr_iscdi=true